Why SAP Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

Shares of SAP SE (NYSE:SAP) rose sharply in today's pre-market trading after the company reported second-quarter financial results.

SAP reported quarterly earnings of 82 cents per share which missed the analyst consensus estimate of $1.19 per share. Quarterly sales came in at $8.92 billion which missed the analyst consensus estimate of $8.96 billion, representing an 8.81% increase over sales from the same period last year, according to data from Benzinga Pro.

SAP shares gained 5.9% to $212.34 in pre-market trading.

Here are some other stocks moving in pre-market trading.

Gainers

• Nature’s Miracle Holding Inc. (NASDAQ:NMHI) rose 183.4% to $0.9779 in pre-market trading after falling 13% on Monday.
• Volato Group, Inc. (NYSE:SOAR) gained 140.5% to $1.15 in pre-market trading after jumping around 20% on Monday.
• Frequency Electronics, Inc. (NASDAQ:FEIM) shares climbed 32% to $13.33 in pre-market trading following fourth-quarter earnings. Also, the company declared a $1.00 special cash dividend.
• MSP Recovery, Inc. (NASDAQ:LIFW) gained 24.6% to $0.6319 in pre-market trading after the company announced a settlement with another group of affiliated P&C insurers.
• Mammoth Energy Services, Inc. (NASDAQ:TUSK) shares gained 23.1% to $4.31 in pre-market trading after the company announced its subsidiary, Cobra Acquisitions, entered into a release and settlement agreement with the Puerto Rico Electric Power Authority.
• MAIA Biotechnology, Inc. (NASDAQ:MAIA) gained 22.9% to $4.61 in pre-market trading after reporting Phase 2 results for lung cancer treatment THIO.
• Professional Diversity Network, Inc. (NASDAQ:IPDN) shares gained 20.2% to $0.59 in pre-market trading.
• New Horizon Aircraft Ltd. (NASDAQ:HOVR) shares gained 13.5% to $0.6105 in pre-market trading after falling over 8% on Monday.
• Mesoblast Limited (NASDAQ:MESO) shares surged 12.5% to $8.50 in pre-market trading. Mesoblast recently started enrollment in Phase 3 trial of Rexlemestrocel-L for chronic low back pain.

Losers

• TransCode Therapeutics, Inc. (NASDAQ:RNAZ) shares fell 57.2% to $0.3395 in pre-market trading. TransCode Therapeutics priced its $3 million public offering of 10 million common shares at $0.30 per share.
• MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) shares fell 30.3% to $3.49 in pre-market trading. MIRA Pharmaceuticals shares jumped 627% on Monday after the company announced new preclinical study results for its novel oral ketamine analog, Ketamir-2.
• CareMax, Inc. (NASDAQ:CMAX) shares fell 25.3% to $3.87 in pre-market trading after surging 228% on Monday.
• Nukkleus Inc. (NASDAQ:NUKK) shares declined 21.5% to $0.3910 in pre-market trading after gaining over 55% on Monday.
• Exicure, Inc. (NASDAQ:XCUR) shares fell 17.5% to $0.41 in pre-market trading after declining around 7% on Monday.
• Castellum, Inc. (NYSE:CTM) fell 15% to $0.17 in pre-market trading. Castellum recently announced a new strategic alliance with Krilla Kaleiwahea.
• Medpace Holdings, Inc. (NASDAQ:MEDP) shares declined 12.6% to $382.00 in pre-market trading after the company reported mixed second-quarter financial results and narrowed its FY24 revenue guidance with its midpoint below estimates.
• Netcapital Inc. (NASDAQ:NCPL) fell 11.8% to $0.0989 in pre-market trading after gaining around 8% on Monday.
• Stem, Inc. (NYSE:STEM) shares dipped 11.4% to $1.17 in pre-market trading after gaining 7% on Monday.
• NXP Semiconductors N.V. (NASDAQ:NXPI) shares fell 9.1% to $258.03 in pre-market trading following mixed second-quarter earnings.

Now Read This:

• Wall Street’s Most Accurate Analysts Say Hold These 3 Utilities Stocks With Over 5% Dividend Yields